节点文献
心肝宝治疗晚期血吸虫病肝纤维化的临床研究
OBSERVATIONS ON XINGANBAO THERAPY OF LIVER FIBROSIS CAUSED BY ADVANCED SCHISTOSOMIASIS
【摘要】 用心肝宝胶囊治疗晚期血吸虫病肝纤维化病人106例。男性58例(54.72%),女性48例(45.28%)。每例均有门静脉高压的诊断依据。每d剂量为2.25g(250mg/粒),分3次口服,连续2个月。结果能使患者症状减轻或消除,肝功能好转,血清白蛋白上升,Y球蛋白下降;免疫功能得到调整;门、脾静脉内径缩小。显效者15例(14.15%),有效80例(75.47%),总有效率为89.62%。
【Abstract】 106 patients with liver fibrosis, 58 men (54.72%) and 48 women (45.28%), were treated with Xinganbao. All of these cases were diagnosed as portal hypertension of advanced schistosomiasis. The drug was given in a daily dose of 2.25g (250mg/capsule) 3 times a day for a succession of 2 months.The result of our study suggests that Xinganbao therapy can relieve and/or eliminate the clinical symptoms of advanced schistosomiasis with liver function recovered, serum albumin raised, γ-globulin decreased, immune function adjusted and caliber of portal and spleen vein much diminished. The total rate of efficacy was 89.62%, of which, 14.15% (15 cases) markedly improved while 75.47% (80 cases) moderately.
- 【文献出处】 中国血吸虫病防治杂志 ,Chinese Journal of Schistosomiasis Control , 编辑部邮箱 ,1991年05期
- 【被引频次】8
- 【下载频次】39